Orphanet: Simple search
x

Search for a clinical trial

* (*) mandatory field

202 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNITED KINGDOM

Greater London
LONDON

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
ITAC: Multicenter, Randomized, Prospective Trial Comparing the Efficacy and Safety of Infliximab to That of Cyclophosphamide in Severe Behçet's Disease.
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Département de Médecine Interne et Immunologie Clinique (DMIIC)

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
MSC: Treatment of Refractory Severe Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells - (Phase I-II) - FR
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCE

NOUVELLE AQUITAINE
LIMOGES

Ongoing trial
AmyDara: A Multicentre Open Label Phase II Study of Daratumumab in AL Amyloidosis Patients Not in VGPR or Better - FR
CHU de Limoges - Hôpital Dupuytren
Service d'hématologie clinique et de thérapie cellulaire

GERMANY

Baden-Württemberg
FREIBURG

Recruiting trial
Ongoing trial
ABASARC: Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosis
Klinik für Pneumologie am Universitätsklinikum Freiburg
Klinik für Pneumologie

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

Ongoing trial
An open-label, phase 1/2 study of melflufen and dexamethasone for patients with al amyloidosis following at least one prior line of therapy - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberINTENT Study: Initial treatment of idiopathic nephrotic syndrome in children with mycophenolate mofetil vs. prednisone: A randomized, controlled, multicenter study - DE
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
TOFFIFE: Tocilizumab for the Treatment of Familial Mediterranean Fever - A randomized, doubleblind, phase II proof of concept study
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

GERMANY

Berlin
BERLIN

Recruiting trial
Ongoing trial
CONSIDER: Canakinumab for Treatment of Adult Onset Still's Disease to Achieve Reduction of Arthritic Manifestation - DE
Charité - Universitätsmedizin Berlin (CCM)
Autoinflammation Reference Center Charité (ARC²)

HUNGARY

Közép-Magyarország
BUDAPEST

ITALY

LAZIO
ROMA

Ongoing trial
Efficacy of monoclonal anti CD 20 antibodies in steroid and cyclosporin dependent nephrotic syndrome in children - IT
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO
Laboratorio di Nefrologia - Divisione di Nefrologia e Dialisi

ITALY

LIGURIA
GENOVA

Ongoing trial
Five-year actively controlled clinical trial in new onset juvenile dermatomyositis
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
U.O. Pediatria II

NETHERLANDS

Utrecht
UTRECHT

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
A randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for untreated patients with systemic light-chain (AL) amyloidosis - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Norfolk
NORWICH

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

BELGIUM

OOST-VLAANDEREN
GENT

Recruiting trial
Ongoing trial
NOVESA studie: GLPG1690 in de behandeling van vroegtijdige diffuse systeemsclerose - BE
Ghent University Hospital - UZ Gent
Department of Rheumatology

FRANCE

BOURGOGNE-FRANCHE-COMTE
DIJON

Ongoing trial
METOGiA: MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial
CHU Dijon Bourgogne - Hôpital François Mitterrand
Service de médecine interne et immunologie clinique

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
CHUSPAN2 : Evaluation of a New Treatment Strategy for Patients With Microscopic Polyangiitis, Polyarteritis Nodosa or Churg Strauss Syndrome Without Poor Prognosis Factors (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
Funded by an IRDiRC memberMSC-LES: Treatment of severe refractory systemic lupus erythematosus by injection of allogeneic mesenchymal stem cells derived from the umbilical cord
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
AST-MOMA: Highdose Chemotherapy and transplantation of CD34 selected stem cell for progressive systemic sclerosis - Modification according to manifestation (Phase II)
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

GERMANY

Bayern
ERLANGEN

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Internistisches Zentrum des Universitätsklinikums Erlangen
Medizinische Klinik 3 - Rheumatologie und Immunologie

GERMANY

Berlin
BERLIN

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Charité - Universitätsmedizin Berlin (CCM)
Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie

ITALY

PUGLIA
BARI

Recruiting trial
Ongoing trial
Combined Therapy With Peg-Interferon alpha, Ribavirin And Rituximab Of Hepatitis C Virus-Related Mixed Cryoglobulinemia - IT
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Unità di Epatologia - Sezione di Medicina Interna e Oncologia Clinica

NETHERLANDS

Groningen
GRONINGEN

SWITZERLAND

Suisse Alémanique
BERN

Recruiting trial
Ongoing trial
GUSTO: Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab - CH
University Hospital Inselspital
Department of Rheumatology, Clinical Immunology Allergology

UNITED KINGDOM

Derbyshire
CHESTERFIELD

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis-GB
University College London Medical School and Royal Free Hospital
Metabolic Bone Disease - Centre for Rheumatology and Connective Tissue Diseases

Multinational clinical trial(s)

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US